Adoram Therapeutics
PrivateLast Round
Grant
May 5, 2025
Total Funding Raised
$1.3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Adoram Therapeutics is a biotechnology company that develops allosteric modulators for the treatment of solid tumors and immune-based diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adoram Therapeutics Comparables
Compare Adoram Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| KyDo Therapeutics | 80% | |
| Palobiofarma S.L. | 80% | |
| Nxera Pharma | 78% |
Adoram Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 5, 2025 | ||||
| Pre Seed | Feb 25, 2025 | ||||
| Seed | Oct 24, 2024 | ||||
| Accelerator | Feb 23, 2024 | ||||
| Grant | Apr 11, 2023 |
Key People
Founding team and executive leadership
Adoram Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fongit | Seed, Pre Seed |
| Innosuisse | Grant |
| Venture Kick | Accelerator, Grant |
| Innosuisse | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 48% MoM.
- May 17, 2026
Monthly visitors increased 82% MoM.
Adoram Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Adoram Therapeutics's valuation, stock price, and market status.
Is Adoram Therapeutics a public or private company?
Adoram Therapeutics is a private company.
What is the current stock price of Adoram Therapeutics?
Adoram Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Adoram Therapeutics worth (valuation)?
Valuation information for Adoram Therapeutics is not publicly available.
Can I buy Adoram Therapeutics stock?
Adoram Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Adoram Therapeutics's last funding round?
Adoram Therapeutics's most recent funding round was Grant on May 15, 2025.
Who are the main investors in Adoram Therapeutics?
Key investors in Adoram Therapeutics include Innosuisse.
Will Adoram Therapeutics IPO soon?
No public IPO plans have been announced for Adoram Therapeutics.
How can I track Adoram Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Adoram Therapeutics's secondary market activity and sign up for updates.